---
figid: PMC10302309__pharmaceutics-15-01604-g002
pmcid: PMC10302309
image_filename: PMC10302309__pharmaceutics-15-01604-g002.jpg
figure_link: /pmc/articles/PMC10302309/figure/F2/
number: Figure 2
figure_title: 'The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular
  Mechanisms to Clinical Application of New Therapeutic Strategies'
caption: EGFR signaling pathway and EGFR-TKIsâ€™ resistance mechanism
article_title: 'The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular
  Mechanisms to Clinical Application of New Therapeutic Strategies'
citation: Carmelo Laface, et al. Pharmaceutics. 2023 Jun;15(6).
year: '2023'
pub_date: 2023-6-
epub_date: 2023-5-27
doi: 10.3390/pharmaceutics15061604
journal_title: Pharmaceutics
journa_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords:
- EGFR mutations
- non-small cell lung cancer
- tyrosine kinase inhibitors
- resistance mechanisms
---
